
IRAK inhibitor 6
CAS No. 1042672-97-8
IRAK inhibitor 6( —— )
Catalog No. M19898 CAS No. 1042672-97-8
IRAK inhibitor 6 is an inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK-4 IC50: 160 nM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 120 | In Stock |
![]() ![]() |
5MG | 201 | In Stock |
![]() ![]() |
10MG | 294 | In Stock |
![]() ![]() |
25MG | 498 | In Stock |
![]() ![]() |
50MG | 709 | In Stock |
![]() ![]() |
100MG | 963 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameIRAK inhibitor 6
-
NoteResearch use only, not for human use.
-
Brief DescriptionIRAK inhibitor 6 is an inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK-4 IC50: 160 nM).
-
DescriptionIRAK inhibitor 6 is an inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK-4 IC50: 160 nM).
-
In VitroIRAK inhibitor 6 significantly improves potency against IRAK-4. Potency effects additive, IRAK inhibitor 6 is the most active compound among these compound tested.
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetAntiviral
-
RecptorIRAK-4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1042672-97-8
-
Formula Weight396.46
-
Molecular FormulaC20H20N4O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mg/mL
-
SMILESCOc1cc(ccc1NC(=O)c1csc(n1)-c1cccnc1)N1CCOCC1
-
Chemical NameN-[2-Methoxy-4-(4-morpholinyl)phenyl]-2-(3-pyridinyl)-4-thiazolecarboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Buckley G et al. IRAK-4 inhibitors. Part 1: a series of amides. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3211-4.
molnova catalog



related products
-
CMX-521
CMX-521 has antiviral activity, inhibits oronavirus activity, and can be used in the study of viral infections.
-
ITMN4077
ITMN4077 has antiviral activity against Hepatitis C virus infected in human HuH7 cells assessed as inhibition of HCV subgenomic replicon replication with an EC50 of 2.131μM.
-
SARS-CoV-2 nsp13-IN-...
SARS-CoV-2 nsp13-IN-1 (compound C1) is a potent inhibitor of nsp13 (non-structural protein 13), selectively inhibiting nsp13 ssDNA+ATPase with an IC50 of 6 μM, but not ssDNA-ATPase, and can be used to study COVID-19.